The price of BrightSpring Health Services Inc (NASDAQ: BTSG) closed at $10.16 in the last session, up 3.04% from day before closing price of $9.86. In other words, the price has increased by $+0.30 from its previous closing price. On the day, 4528708 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
We take a closer look at BTSG’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 6.28 whereas as Long-Term Debt/Eq ratio is at 6.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, HSBC Securities on March 06, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On February 27, 2024, Deutsche Bank Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $11.50.
On February 20, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $15.Wells Fargo initiated its Overweight rating on February 20, 2024, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 15 ’24 when ROUSSEAU JON B bought 18,400 shares for $8.09 per share. The transaction valued at 148,856 led to the insider holds 369,763 shares of the business.
ROUSSEAU JON B bought 18,400 shares of BTSG for $148,856 on Mar 15 ’24. The insider now owns 1,025,636 shares after completing the transaction at $8.09 per share. On Mar 15 ’24, another insider, Mattingly James F Jr, who serves as the insider of the company, bought 6,080 shares for $8.26 each. As a result, the insider paid 50,221 and bolstered with 134,780 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTSG now has a Market Capitalization of 1.74B and an Enterprise Value of 5.40B. Its current Enterprise Value per Revenue stands at 0.61 whereas that against EBITDA is 15.44.
Stock Price History:
Over the past 52 weeks, BTSG has reached a high of $12.14, while it has fallen to a 52-week low of $7.85. The 50-Day Moving Average of the stock is 9.98, while the 200-Day Moving Average is calculated to be 9.98.
Shares Statistics:
According to the various share statistics, BTSG traded on average about 3.10M shares per day over the past 3-months and 3.04M shares per day over the past 10 days. A total of 171.19M shares are outstanding, with a floating share count of 52.66M. Shares short for BTSG as of Feb 29, 2024 were 9.23M with a Short Ratio of 3.71, compared to 8.8M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.39% and a Short% of Float of 18.20%.
Earnings Estimates
The company has 8 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0.18, with high estimates of $0.36 and low estimates of $0.12.
Analysts are recommending an EPS of between $1.25 and $0.35 for the fiscal current year, implying an average EPS of $0.59. EPS for the following year is $0.8, with 10 analysts recommending between $1.48 and $0.52.
Revenue Estimates
A total of 11 analysts have provided revenue estimates for BTSG’s current fiscal year. The highest revenue estimate was $9.57B, while the lowest revenue estimate was $9.36B, resulting in an average revenue estimate of $9.44B. In the same quarter a year ago, actual revenue was $8.83B, up 7.00% from the average estimate. Based on 11 analysts’ estimates, the company’s revenue will be $10.25B in the next fiscal year. The high estimate is $10.49B and the low estimate is $10.13B. The average revenue growth estimate for next year is up 8.60% from the average revenue estimate for this year.
